The wellness and healthcare sectors are undergoing a major transformation driven by the meteoric rise of weight loss drugs like Wegovy and Zepbound. Once synonymous with structured dieting programs, the industry has pivoted sharply toward pharmacological solutions, leaving traditional players like WeightWatchers reeling. The company's recent bankruptcy filing underscores the seismic shift in consumer behavior and the growing dominance of GLP-1-based medications in the fight against obesity.